- Home
- SKM vs BMRN Comparison
SKM vs BMRN Comparison
Compare SKM & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SKM | BMRN |
|---|---|---|
| Founded | 1984 | 1996 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 11.4B |
| IPO Year | 1999 | 1999 |
Fundamental Metrics
Financial Performance| Metric | SKM | BMRN |
|---|---|---|
| Price | $34.88 | $59.91 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 18 |
| Target Price | N/A | ★ $88.22 |
| AVG Volume (30 Days) | ★ 2.4M | 1.5M |
| Earning Date | 05-08-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.46% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.54 |
| Revenue | N/A | ★ $1,313,646,000.00 |
| Revenue This Year | $4.41 | $15.02 |
| Revenue Next Year | $1.85 | $12.23 |
| P/E Ratio | ★ $31.64 | $112.44 |
| Revenue Growth | N/A | ★ 17.62 |
| 52 Week Low | $19.66 | $49.26 |
| 52 Week High | $47.18 | $66.28 |
Technical Indicators
Market Signals| Indicator | SKM | BMRN |
|---|---|---|
| Relative Strength Index (RSI) | 56.03 | 53.95 |
| Support Level | $29.27 | $57.60 |
| Resistance Level | $36.89 | $61.29 |
| Average True Range (ATR) | 1.13 | 1.40 |
| MACD | 0.38 | -0.10 |
| Stochastic Oscillator | 75.41 | 45.63 |
Price Performance
Historical ComparisonAbout SKM SK Telecom Co. Ltd.
SK Telecom is South Korea's largest wireless telecom operator, with 32 million mobile customers. The firm also owns SK Broadband (formerly Hanaro Telecom), which has 7.2 million broadband customers and 9.5 million pay TV customers (6.7 million IPTV and 2.8 million Cable TV). While the firm also purchased stakes in businesses in security and semiconductor memory production, as well as developing e-commerce and internet platform businesses, these were all spun off into the separate SK Square business in November 2021. The company was formed after SK Group purchased KT's mobile business in 1994.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.